Optiscan Imaging Ltd

Optiscan Imaging (ASX: OIL) and US medical group Mayo Clinic have joined forces to advance the development of a digital confocal laser endomicroscopic imaging system for use in robot-assisted breast cancer surgery. The two parties are conducting the work as part of the 24-month “know-how” agreement they signed in May 2024, bringing together experts from […]

Commercial-stage medical technology company Optiscan Imaging (ASX: OIL) has completed beta phase testing of its cloud-based telepathology platform developed in partnership with Prolucid Technologies. The platform is believed to represent a significant advancement in digital pathology, enabling real-time collaboration on patient imaging sessions and allowing remote users to make immediate and informed decisions. The phase […]

Optiscan Imaging (ASX: OIL) has revealed the InVue microscopic medical imaging device, designed to benefit the surgical market by providing real-time digital pathology access to surgeons. The Australian-made device was developed in partnership with local product development company Design + Industry for use in a wide range of clinical settings including cancer diagnosis and treatment. […]

For all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t changed much in decades – or even centuries. Take X-rays, which are widely used despite the wee problem of irradiating the patients. And that’s because they are cheap and convenient. The underlying tech hasn’t really moved on since 1895, when […]